Cargando…

Psychometric properties of the osteoporosis assessment questionnaire (OPAQ) 2.0: results from the multiple outcomes of raloxifene evaluation (MORE) study

BACKGROUND: We explored psychometric properties of the Osteoporosis Assessment Questionnaire 2.0 in terms of reliability, validity, and responsiveness with generic, clinical, demographic, and preference-based data collected from a population of postmenopausal women with osteoporosis. METHODS: The Mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Wei, Burge, Russel, Naegeli, April N, Shih, Jeremy, Alam, Jahangir, Gold, Deborah T, Silverman, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246554/ https://www.ncbi.nlm.nih.gov/pubmed/25403238 http://dx.doi.org/10.1186/1471-2474-15-374

Ejemplares similares

Development of the osteoporosis assessment questionnaire—physical function (OPAQ-PF): an osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function
por: Naegeli, A. N., et al.
Publicado: (2013)

Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function
por: Nixon, A., et al.
Publicado: (2014)

Use of health-related quality of life measures to predict health utility in postmenopausal osteoporotic women: results from the Multiple Outcomes of Raloxifene Evaluation study
por: Burge, Russel, et al.
Publicado: (2013)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

Interpreting change from patient reported outcome (PRO) endpoints: patient global ratings of concept versus patient global ratings of change, a case study among osteoporosis patients
por: Nixon, Annabel, et al.
Publicado: (2016)

Adaptation of a Danish online version of the Oxford Physical Activity Questionnaire (OPAQ) for secondary school students—a pilot study
por: Lykkegaard, Charlotte Raadkjær, et al.
Publicado: (2022)

Fractures in women treated with raloxifene or alendronate: a retrospective database analysis
por: Foster, Shonda A, et al.
Publicado: (2013)

Effect of aerobic exercise and raloxifene combination therapy on senile osteoporosis
por: Zhao, Chengjin, et al.
Publicado: (2016)

Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women
por: Um, Mi Jung, et al.
Publicado: (2017)

Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis
por: Kim, Yeesuk, et al.
Publicado: (2020)

The Development of the Genital Psoriasis Sexual Frequency Questionnaire (GenPs-SFQ) to Assess the Impact of Genital Psoriasis on Sexual Health
por: Gottlieb, Alice B., et al.
Publicado: (2017)

Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment
por: Nagai, Noriaki, et al.
Publicado: (2018)

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
por: Messalli, Enrico M, et al.
Publicado: (2010)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Compliance and persistence with osteoporosis medications: A critical review of the literature
por: Silverman, Stuart, et al.
Publicado: (2010)

Investigation of the treatment potential of Raloxifene-loaded polymeric nanoparticles in osteoporosis: In-vitro and in-vivo analyses
por: Guo, Zhonghua, et al.
Publicado: (2023)

KIDMED 2.0, An update of the KIDMED questionnaire: Evaluation of the psychometric properties in youth
por: López-Gajardo, Miguel A., et al.
Publicado: (2022)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
por: Vogel, Victor G
Publicado: (2008)

Combined treatment with dexamethasone and raloxifene totally abrogates osteoporosis and joint destruction in experimental postmenopausal arthritis
por: Islander, Ulrika, et al.
Publicado: (2011)

Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
por: Chen, Mingsheng, et al.
Publicado: (2016)

A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment
por: Lee, Jihyoun, et al.
Publicado: (2021)

Raloxifene in Hemodialysis Patients
por: Keller, Frieder
Publicado: (2012)

Oxidative Stress and Raloxifene
por: Akgol, Gurkan, et al.
Publicado: (2012)

Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial
por: Lee, You-Bin, et al.
Publicado: (2022)

Safety of Raloxifene in Hemodialysis Patients
por: Jacobsen, Didy
Publicado: (2012)

Co‐consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participants
por: Clarke, John D., et al.
Publicado: (2023)

Gratitude Questionnaire–20 Items (G20): A Cross-Cultural, Psychometric and Crowdsourcing Analysis
por: Bernabe-Valero, Gloria, et al.
Publicado: (2020)

Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2008)

Comparison of the Prescribing Pattern of Bisphosphonate and Raloxifene in Korean Women with Osteoporosis: From a National Health Insurance Claims Database
por: Kim, Jungmee, et al.
Publicado: (2015)

Raloxifene improves TNF-α-induced osteogenic differentiation inhibition of bone marrow mesenchymal stem cells and alleviates osteoporosis
por: Yang, Fenghe, et al.
Publicado: (2020)

ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022)

Hemostatic Effects of Raloxifene in Ovariectomized Rats
por: Alva-Chavarría, Denys, et al.
Publicado: (2023)

The Development of a Patient-Reported Outcome Measure for Assessment of Genital Psoriasis Symptoms: The Genital Psoriasis Symptoms Scale (GPSS)
por: Gottlieb, Alice B., et al.
Publicado: (2017)

Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat
por: Stuermer, E. K., et al.
Publicado: (2008)

Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
por: Shin, Chang Jin, et al.
Publicado: (2016)

Raloxifene for older women: a review of the literature
por: Hansdóttir, Helga
Publicado: (2008)

Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride
por: Reddy, Reguri Buchi, et al.
Publicado: (2012)

Effects of Raloxifene on Bone Metabolism in Hemodialysis Patients
por: Iwamoto, Jun
Publicado: (2012)

Significant Effect of Raloxifene on Bone in Hemodialysis Patients
por: Ravn, Pernille
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_us2qm0lnsa23fn2hcklfalkb8q